Search | Search by Center | Search by Source | Keywords in Title
Layden J, Cao L, Corcoran P, Weaver FM, Uprichard S. Blocking the HCV entry factor NPC1L1 via ezetimibe improves HCV Outcomes. Poster session presented at: American Association for the Study of Liver Diseases Annual Meeting; 2013 Nov 4; Washington, DC.